Skip to main content

Neoadjuvant chemoradiation therapy for the treatment of esophageal carcinoma

International Journal of Clinical Oncology volume 13, Article number: 474 (2008) Cite this article

Abstract

An esophagectomy with three-field lymph node dissection is the standard therapy for esophageal cancer in many countries, including Japan. However, the results of esophagectomy are still unsatisfactory in comparison to the results of surgical treatment for gastric cancer or colon cancer. On the other hand, definitive chemoradiation therapy has recently shown progress as a treatment modality for resectable esophageal cancer, with data indicating the potential efficacy of combination therapy with chemoradiation and an esophagectomy. In fact, preoperative chemoradiotherapy for resectable esophageal cancer is becoming a standard therapy in Europe and North America. The latest metaanalysis concerning neoadjuvant chemoradiotherapy for resectable esophageal cancer concluded that a significant survival benefit was evident with preoperative chemoradiotherapy. However, there are still no supportive data for neoadjuvant chemoradiation and surgery from a well-designed large-scale randomized control trial (RCT). A well-designed large-scale RCT is needed to determine the utility of neoadjuvant chemoradiation. Future trials based on precise diagnosis and surgical procedures are required for the adequate interpretation of the results of treatment for resectable esophageal cancer. Of course, quality control of the operation is a very important factor, because operative mortality influences these results.

This is a preview of subscription content, access via your institution.

Access options

Buy single article

Instant access to the full article PDF.

43,34 €

Price includes VAT (Finland)
Tax calculation will be finalised during checkout.

References

  1. Isono K, Sato H, Nakayama K (1991) Results of a nationwide study on the three-field lymph node dissection of esophageal cancer. Oncology 48:411–420

    PubMed  CAS  Article  Google Scholar 

  2. Kato H (1995) Lymph node dissection for thoracic esophageal carcinoma. Two- and three-field lymph node dissection. Ann Chir Gynaecol 84:193–199

    PubMed  CAS  Google Scholar 

  3. Ferahkose Z, Anadol AZ, Gokbayir H, et al. (2006) Three-field lymph node dissection in the treatment of thoracic esophageal carcinoma: the Turkish experience. Dis Esophagus19:232–237

    PubMed  Article  CAS  Google Scholar 

  4. Herskovic A, Martz K, al-Sarraf M, et al. (1992) Combined chemotherapy and radiotherapy compared with radiotherapy alone in patients with cancer of the esophagus. N Engl J Med 326:1593–1598

    PubMed  CAS  Google Scholar 

  5. al-Sarraf M, Martz K, Herskovic A, et al. (1997) Progress report of combined chemoradiotherapy versus radiotherapy alone in patients with esophageal cancer: an intergroup study. J Clin Oncol 15:277–284

    PubMed  CAS  Google Scholar 

  6. Cooper JS, Guo MD, Herskovic A, et al. (1999) Chemoradiotherapy of locally advanced esophageal cancer: long-term follow-up of a prospective randomized trial (RTOG 85-01). Radiation Therapy Oncology Group. JAMA 281:1623–1627

    PubMed  Article  CAS  Google Scholar 

  7. Minsky BD, Pajak TF, Ginsberg RJ, et al. (2002) INT 0123 (Radiation Therapy Oncology Group 94-05) phase III trial of combinedmodality therapy for esophageal cancer: high-dose versus standard-dose radiation therapy. J Clin Oncol 20:1167–1174

    PubMed  Article  CAS  Google Scholar 

  8. Ohtsu A (2004) Chemoradiotherapy for esophageal cancer: current status and perspectives. Int J Clin Oncol 9:444–450

    PubMed  Article  Google Scholar 

  9. Stahl M, Stuschke M, Lehmann N, et al. (2005) Chemoradiation with and without surgery in patients with locally advanced squamous cell carcinoma of the esophagus. J Clin Oncol 23:2310–2317

    PubMed  Article  Google Scholar 

  10. Burmeister BH, Smithers BM, Gebski V, et al. (2005) Surgery alone versus chemoradiotherapy followed by surgery for resectable cancer of the oesophagus: a randomised controlled phase III trial. Lancet Oncol 6:659–668

    PubMed  Article  Google Scholar 

  11. Nygaard K, Hagen S, Hansen HS, et al. (1992) Pre-operative radiotherapy prolongs survival in operable esophageal carcinoma: a randomized, multicenter study of pre-operative radiotherapy and chemotherapy. The second Scandinavian trial in esophageal cancer. World J Surg 16:1104–1109; discussion 1110

    PubMed  Article  CAS  Google Scholar 

  12. Walsh TN, Noonan N, Hollywood D, et al. (1996) A comparison of multimodal therapy and surgery for esophageal adenocarcinoma. N Engl J Med 335:462–467

    PubMed  Article  CAS  Google Scholar 

  13. Fiorica F, Di Bona D, Schepis F, et al. (2004) Preoperative chemoradiotherapy for oesophageal cancer: a systematic review and meta-analysis. Gut 53(7):925–930

    PubMed  Article  CAS  Google Scholar 

  14. Urschel JD, Vasan H (2003) A meta-analysis of randomized controlled trials that compared neoadjuvant chemoradiation and surgery to surgery alone for resectable esophageal cancer. Am J Surg 185:538–543

    PubMed  Article  Google Scholar 

  15. Visser BC, Venook AP, Patti MG (2003) Adjuvant and neoadjuvant therapy for esophageal cancer: a critical reappraisal. Surg Oncol 12:1–7

    PubMed  Article  Google Scholar 

  16. Apinop C, Puttisak P, Preecha N (1994) A prospective study of combined therapy in esophageal cancer. Hepatogastroenterology 41:391–393

    PubMed  CAS  Google Scholar 

  17. Le Prise E, Etienne PL, Meunier B, et al. (1994) A randomized study of chemotherapy, radiation therapy, and surgery versus surgery for localized squamous cell carcinoma of the esophagus. Cancer 73:1779–1784

    PubMed  Article  Google Scholar 

  18. Bosset JF, Gignoux M, Triboulet JP, et al. (1997) Chemoradiotherapy followed by surgery compared with surgery alone in squamous-cell cancer of the esophagus. N Engl J Med 337:161–167

    PubMed  Article  CAS  Google Scholar 

  19. Urba SG, Orringer MB, Turrisi A, et al. (2001) Randomized trial of preoperative chemoradiation versus surgery alone in patients with locoregional esophageal carcinoma. J Clin Oncol 19:305–313

    PubMed  CAS  Google Scholar 

  20. Graham AJ, Shrive FM, Ghali WA, et al. (2007) Defining the optimal treatment of locally advanced esophageal cancer: a systematic review and decision analysis. Ann Thorac Surg 83:1257–1264

    PubMed  Article  Google Scholar 

  21. Malthaner RA, Wong RK, Rumble RB, et al. (2004) Neoadjuvant or adjuvant therapy for resectable esophageal cancer: a systematic review and meta-analysis. BMC Med 2:35

    PubMed  Article  Google Scholar 

  22. Lee JL, Park SI, Kim SB, et al. (2004) A single institutional phase III trial of preoperative chemotherapy with hyperfractionation radiotherapy plus surgery versus surgery alone for resectable esophageal squamous cell carcinoma. Ann Oncol 15:947–954

    PubMed  Article  CAS  Google Scholar 

  23. Gebski V, Burmeister B, Smithers BM, et al. (2007) Survival benefits from neoadjuvant chemoradiotherapy or chemotherapy in oesophageal carcinoma: a meta-analysis. Lancet Oncol 8:226–234

    PubMed  Article  CAS  Google Scholar 

  24. Tepper J, Krasna MJ, Niedzwiecki D, et al. (2008) Phase III trial of trimodality therapy with cisplatin, fluorouracil, radiotherapy, and surgery compared with surgery alone for esophageal cancer: CALGB 9781. J Clin Oncol 26:1086–1092

    PubMed  Article  CAS  Google Scholar 

  25. Geh JI, Bond SJ, Bentzen SM, et al. (2006) Systematic overview of preoperative (neoadjuvant) chemoradiotherapy trials in oesophageal cancer: evidence of a radiation and chemotherapy dose response. Radiother Oncol 78:236–244

    PubMed  Article  CAS  Google Scholar 

  26. Forastiere AA, Orringer MB, Perez-Tamayo C, et al. (1993) Preoperative chemoradiation followed by transhiatal esophagectomy for carcinoma of the esophagus: final report. J Clin Oncol 11:1118–1123

    PubMed  CAS  Google Scholar 

  27. Bates BA, Detterbeck FC, Bernard SA, et al. (1996) Concurrent radiation therapy and chemotherapy followed by esophagectomy for localized esophageal carcinoma. J Clin Oncol 14:156–163

    PubMed  CAS  Google Scholar 

  28. Vogel SB, Mendenhall WM, Sombeck MD, et al. (1995) Downstaging of esophageal cancer after preoperative radiation and chemotherapy. Ann Surg 221:685–693; discussion 693–695

    PubMed  Article  CAS  Google Scholar 

  29. Bessell JR, Devitt PG, Gill PG, et al. (1996) Prolonged survival follows resection of oesophageal SCC downstaged by prior chemoradiotherapy. Aust N Z J Surg 66:214–217

    PubMed  Article  CAS  Google Scholar 

  30. Stahl M, Wilke H, Fink U, et al. (1996) Combined preoperative chemotherapy and radiotherapy in patients with locally advanced esophageal cancer. Interim analysis of a phase II trial. J Clin Oncol 14:829–837

    PubMed  CAS  Google Scholar 

  31. Jones DR, Detterbeck FC, Egan TM, et al. (1997) Induction chemoradiotherapy followed by esophagectomy in patients with carcinoma of the esophagus. Ann Thorac Surg; 64:185–191; discussion 191–192

    PubMed  Article  CAS  Google Scholar 

  32. Ross P, Nicolson M, Cunningham D, et al. (2002) Prospective randomized trial comparing mitomycin, cisplatin, and protracted venous-infusion fluorouracil (PVI 5-FU) With epirubicin, cisplatin, and PVI 5-FU in advanced esophagogastric cancer. J Clin Oncol 20:1996–2004

    PubMed  Article  CAS  Google Scholar 

  33. Webb A, Cunningham D, Scarffe JH, et al. (1997) Randomized trial comparing epirubicin, cisplatin, and fluorouracil versus fluorouracil, doxorubicin, and methotrexate in advanced esophagogastric cancer. J Clin Oncol 15:261–267

    PubMed  CAS  Google Scholar 

  34. Khushalani NI, Leichman CG, Proulx G, et al. (2002) Oxaliplatin in combination with protracted-infusion fluorouracil and radiation: report of a clinical trial for patients with esophageal cancer. J Clin Oncol 20:2844–2850

    PubMed  Article  CAS  Google Scholar 

  35. Sumpter K, Harper-Wynne C, Cunningham D, et al. (2005) Report of two protocol planned interim analyses in a randomised multicentre phase III study comparing capecitabine with fluorouracil and oxaliplatin with cisplatin in patients with advanced oesophagogastric cancer receiving ECF. Br J Cancer 92:1976–1983

    PubMed  Article  CAS  Google Scholar 

  36. Cunningham D, Starling N, Rao S, et al. (2008) Capecitabine and oxaliplatin for advanced esophagogastric cancer. N Engl J Med 358:36–46

    PubMed  Article  CAS  Google Scholar 

  37. Airoldi M, Cortesina G, Giordano C, et al. (2003) Docetaxel and vinorelbine: an effective regimen in recurrent squamous cell esophageal carcinoma. Med Oncol 20:19–24

    PubMed  Article  CAS  Google Scholar 

  38. Pennathur A, Luketich JD, Landreneau RJ, et al. (2008) Longterm results of a phase II trial of neoadjuvant chemotherapy followed by esophagectomy for locally advanced esophageal neoplasm. Ann Thorac Surg 85:1930–1936; discussion 1936–1937

    PubMed  Article  Google Scholar 

  39. Fujitani K, Ajani JA, Crane CH, et al. (2007) Impact of induction chemotherapy and preoperative chemoradiotherapy on operative morbidity and mortality in patients with locoregional adenocarcinoma of the stomach or gastroesophageal junction. Ann Surg Oncol 14:1305–1311

    PubMed  Article  Google Scholar 

  40. Bianco C, Tortora G, Bianco R, et al. (2002) Enhancement of antitumor activity of ionizing radiation by combined treatment with the selective epidermal growth factor receptor-tyrosine kinase inhibitor ZD1839 (Iressa). Clin Cancer Res 8:3250–3258

    PubMed  CAS  Google Scholar 

  41. Sartor CI (2004) Mechanisms of disease: radiosensitization by epidermal growth factor receptor inhibitors. Nat Clin Pract Oncol 1:80–87

    PubMed  Article  CAS  Google Scholar 

  42. Bonner JA, Harari PM, Giralt J, et al. (2006) Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck. N Engl J Med 354:567–578

    PubMed  Article  CAS  Google Scholar 

  43. Ajani JA, Moiseyenko VM, Tjulandin S, et al. (2007) Clinical benefit with docetaxel plus fluorouracil and cisplatin compared with cisplatin and fluorouracil in a phase III trial of advanced gastric or gastroesophageal cancer adenocarcinoma: the V-325 Study Group. J Clin Oncol 25:3205–3209

    PubMed  Article  CAS  Google Scholar 

  44. Kleinberg L, Forastiere AA (2007) Chemoradiation in the management of esophageal cancer. J Clin Oncol 25:4110–4117

    PubMed  Article  CAS  Google Scholar 

  45. Kelsen DP, Ginsberg R, Pajak TF, et al. (1998) Chemotherapy followed by surgery compared with surgery alone for localized esophageal cancer. N Engl J Med 339:1979–1984

    PubMed  Article  CAS  Google Scholar 

  46. Medical Research Council Oesophageal Cancer Working Group (2002) Surgical resection with or without preoperative chemotherapy in oesophageal cancer: a randomised controlled trial. Lancet 359:1727–1733

    Article  Google Scholar 

  47. Maipang T, Vasinanukorn P, Petpichetchian C, et al. (1994) Induction chemotherapy in the treatment of patients with carcinoma of the esophagus. J Surg Oncol 56:191–197

    PubMed  Article  CAS  Google Scholar 

  48. Ancona E, Ruol A, Castoro C, et al. (1997) First-line chemotherapy improves the resection rate and long-term survival of locally advanced (T4, any N, M0) squamous cell carcinoma of the thoracic esophagus: final report on 163 consecutive patients with 5-year follow-up. Ann Surg 226:714–723; discussion 723–724

    PubMed  Article  CAS  Google Scholar 

  49. Law S, Fok M, Chow S, et al. (1997) Preoperative chemotherapy versus surgical therapy alone for squamous cell carcinoma of the esophagus: a prospective randomized trial. J Thorac Cardiovasc Surg 114:210–217

    PubMed  Article  CAS  Google Scholar 

  50. Kaklamanos IG, Walker GR, Ferry K, et al. (2003) Neoadjuvant treatment for resectable cancer of the esophagus and the gastroesophageal junction: a meta-analysis of randomized clinical trials. Ann Surg Oncol 10:754–761

    PubMed  Article  Google Scholar 

  51. Urschel JD, Vasan H, Blewett CJ (2002) A meta-analysis of randomized controlled trials that compared neoadjuvant chemotherapy and surgery to surgery alone for resectable esophageal cancer. Am J Surg 183:274–279

    PubMed  Article  Google Scholar 

  52. Igaki H, Kato H, Ando N, et al. (2008) A randomized trial of postoperative adjuvant chemotherapy with cisplatin and 5-fluorouracil versus neoadjuvant chemotherapy for clinical stage II/III squamous cell carcinoma of the thoracic esophagus (JCOG9907) (abstract). J Clin Oncol 26(Suppl):4510

    Google Scholar 

  53. Luu TD, Gaur P, Force SD, et al. (2008) Neoadjuvant chemoradiation versus chemotherapy for patients undergoing esophagectomy for esophageal cancer. Ann Thorac Surg 85:1217–1223; discussion 1223–1224

    PubMed  Article  Google Scholar 

  54. Nabeya Y, Ochiai T, Matsubara H, et al. (2005) Neoadjuvant chemoradiotherapy followed by esophagectomy for initially resectable squamous cell carcinoma of the esophagus with multiple lymph node metastasis. Dis Esophagus 18:388–397

    PubMed  Article  Google Scholar 

Download references

Author information

Affiliations

  1. Department of Frontier Surgery, Graduate School of Medicine, Chiba University, 1-8-1 Inohana, Chuo-ku, Chiba, 260-8670, Japan

    Hisahiro Matsubara

Authors
  1. Hisahiro Matsubara
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Hisahiro Matsubara.

About this article

Cite this article

Matsubara, H. Neoadjuvant chemoradiation therapy for the treatment of esophageal carcinoma. Int J Clin Oncol 13, 474 (2008). https://doi.org/10.1007/s10147-008-0853-4

Download citation

  • Received:

  • Published:

  • DOI: https://doi.org/10.1007/s10147-008-0853-4

Key words

  • Esophageal cancer
  • Surgery
  • Neoadjuvant chemoradiation